Frank Aboubakar Nana
Cliniques Universitaires Saint-Luc(BE)de Duve Institute(BE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Peptidase Inhibition and Analysis, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)(2022)92 cited
- → Lung immunoglobulin A immunity dysregulation in cystic fibrosis(2020)35 cited
- → Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer(2023)23 cited
- → Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry(2025)15 cited
- → A pregnant patient with ALK‑positive non‑small cell lung cancer treated with alectinib: A case report and review of the literature(2022)11 cited
- → Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment(2023)11 cited
- → OA09.06 Molecular Alterations and Estimated Indoor Radon in NSCLC Patients from the French National Cancer Institute Registry: Radon France Study(2018)10 cited
- → Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer(2023)6 cited
- → Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes(2024)6 cited
- → Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)5 cited